Rosiglitazone Exerts an Anti-depressive Effect in Unpredictable Chronic Mild-Stress-Induced Depressive Mice by Maintaining Essential Neuron Autophagy and Inhibiting Excessive Astrocytic Apoptosis

There is increasing interest in the association between depression and the development of metabolic diseases. Rosiglitazone, a therapeutic drug used to treat type 2 diabetes mellitus, has shown neuroprotective effects in patients with stroke and Alzheimer’s disease. The present study was performed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zhan, Zhang, Ling, Guo, Xu-Dong, Cao, Lu-Lu, Xue, Teng-Fei, Zhao, Xiao-Jie, Yang, Dan-Dan, Yang, Jin, Ji, Juan, Huang, Ji-Ye, Sun, Xiu-Lan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603714/
https://www.ncbi.nlm.nih.gov/pubmed/28959186
http://dx.doi.org/10.3389/fnmol.2017.00293

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5603714/
https://www.ncbi.nlm.nih.gov/pubmed/28959186
http://dx.doi.org/10.3389/fnmol.2017.00293

Ejemplares similares